A detailed history of Richard P Slaughter Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Richard P Slaughter Associates Inc holds 36,701 shares of BMY stock, worth $2.1 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
36,701
Previous 34,564 6.18%
Holding current value
$2.1 Million
Previous $1.44 Million 32.33%
% of portfolio
0.55%
Previous 0.38%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$39.66 - $51.75 $84,753 - $110,589
2,137 Added 6.18%
36,701 $1.9 Million
Q2 2024

Jul 10, 2024

BUY
$40.25 - $52.99 $162,891 - $214,450
4,047 Added 13.26%
34,564 $1.44 Million
Q1 2024

Apr 09, 2024

BUY
$47.98 - $54.4 $52,873 - $59,948
1,102 Added 3.75%
30,517 $1.65 Million
Q4 2023

Jan 08, 2024

BUY
$48.48 - $57.85 $145,440 - $173,550
3,000 Added 11.36%
29,415 $1.51 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $253,268 - $283,193
4,375 Added 19.85%
26,415 $1.53 Million
Q2 2023

Jul 06, 2023

BUY
$63.71 - $70.74 $47,782 - $53,054
750 Added 3.52%
22,040 $1.41 Million
Q1 2023

Apr 18, 2023

BUY
$65.71 - $74.53 $111,378 - $126,328
1,695 Added 8.65%
21,290 $1.48 Million
Q4 2022

Jan 09, 2023

BUY
$68.48 - $81.09 $41,909 - $49,627
612 Added 3.22%
19,595 $0
Q3 2022

Oct 11, 2022

BUY
$0.13 - $76.84 $2,127 - $1.26 Million
16,363 Added 624.54%
18,983 $1.35 Million
Q2 2022

Jul 08, 2022

BUY
$72.62 - $79.98 $190,264 - $209,547
2,620 New
2,620 $201,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Richard P Slaughter Associates Inc Portfolio

Follow Richard P Slaughter Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard P Slaughter Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Richard P Slaughter Associates Inc with notifications on news.